Together these experiments demonstrate that systemic administration of a STING agonist in combination with radiation enhances local control in HNSCC and suggests STING expression in the tumor is required for maximal therapeutic effects. The gene discussed is STING1; the disease is head and neck squamous cell carcinoma.